Althia is a Spanish biomedical company focused on personalized predictive oncology, offering diagnostic and treatment activities for cancer patients. The company operates advanced diagnostic laboratories and translational research facilities in Barcelona and Granada and maintains offices in Madrid. Its three areas of activity are care in diagnosis/prognosis, translational research, and SD-IGRT treatment, with SD-IGRT currently being implemented. Althia will use the €3M funding to strengthen the business line and to initiate diagnostic services and treatment activity for cancer patients using single-dose image-guided radiation therapy. The company was formed in 2007 by Dr. Carlos Cordon-Cardo and Dr. Zvi Fuchs and is supported by Santiago de Torres and Isabel Lozano.

Total raised

$4M

Funding rounds

1

Latest round

Equity

Latest activity

Nov 2012